Advanced Search

 

Study ID Status Title Patient Level Data
113719 Completed A randomised, double-blind, placebo-controlled, parallel group, multicentre study to evaluate the efficacy and safety of fluticasone furoate/vilanterol trifenatate (FF/VI) inhalation powder delivered once daily for 12 weeks in the treatment of asthma in adolescent and adult subjects of Asian ancestry currently treated with low to mid-strength inhaled corticosteroid or low-strength combination therapy. Study Listed on ClinicalStudyDataRequest.com
113746 Completed A double blind, randomized, placebo controlled, cross-over study to Examine the pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in nicotine abstained otherwise healthy smokers Study Listed on ClinicalStudyDataRequest.com
113748 Completed A randomized, placebo-controlled, double-masked, parallel group study to evaluate the safety, tolerability, and pharmacokinetic profile of repeat doses of pazopanib eye drops in healthy adult subjects
113758 Terminated A randomized, open-label, Phase II, 2-arm multi-center trial comparing maintenance therapy with pazopanib or pemetrexed in non-progressing subjects with metastatic stage IVA and IVB non-squamous Non-small Cell Lung Cancer (NSCLC) after induction therapy with carboplatin + pemetrexed or cisplatin + pemetrexed
113771 Completed A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113782 Completed A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease Study Listed on ClinicalStudyDataRequest.com
113808 Completed Efficacy, immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine (444563), in healthy infants Study Listed on ClinicalStudyDataRequest.com
113809 Completed Immunological non-inferiority between two process-manufactured influenza vaccines in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113810 Terminated Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 9 years Study Listed on ClinicalStudyDataRequest.com
113814 Completed Zyban PEM study
113834 Completed Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin
113847 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza (H1N1) candidate vaccine (GSK2340274A) in Japanese children aged 6 months to 17 years Study Listed on ClinicalStudyDataRequest.com
113849 Completed Recruitment and safety of Valtrex in HIV+ patients with CD4 < 100
113849_1 Completed Recruitment and safety of Valtrex in HIV+ patients with CD4 < 100
113865 Completed Fluticasone propionate-salmeterol combination adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD)
113866 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113872 Completed A Randomized, Double-Blind, Parallel Group study of ADVAIR™ DISKUS™ 100/50 and FLOVENT™DISKUS™ 100, both twice daily, in a Pediatric Population during the Fall Viral Season. Study Listed on ClinicalStudyDataRequest.com
113874 Completed A Randomized, Double-Blind, Parallel Group, Multicenter Study of the Effects of Fluticasone Propionate/Salmeterol Combination Product 250/50mcg BID (ADVAIR DISKUS™) in Comparison to Salmeterol 50mcg BID (SEREVENT DISKUS™) on the Rate of Exacerbations of COPD Following Hospitalization Study Listed on ClinicalStudyDataRequest.com
113877 Completed A study of fluticasone propionate/salmeterol DISKUS combination product 250/50 mcg twice daily plus tiotropium 18 mcg daily versus placebo DISKUS twice daily plus tiotropium 18 mcg daily on exercise time and physiological parameters in subjects with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
113883 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza (H1N1) candidate vaccine (GSK2340274A) in children aged 10 to less than 18 years Study Listed on ClinicalStudyDataRequest.com
113898 Completed Outcomes Associated with Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation
113899 Completed Differences in the risk of re-hospitalization and other COPD-related (Chronic Obstructive Pulmonary Disease) exacerbations and costs for patients receiving fluticasone propionate-salmeterol xinafoate combination 250/50mcg (FSC) versus anticholinergics [i.e. tiotropium (TIO) and ipratropium or combination ipratropium-albuterol (IPR) post-hospitalization or ED visit for the treatment of COPD.
113900 Completed Clinical and Economic Burden of Patients with Chronic Obstructive Pulmonary Disease in a Medicaid Population
113901 Completed Outcomes for Chronic Obstructive Pulmonary Disease moderate exacerbators initiating treatment
113902 Completed Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg versus Anticholinergics in a Comorbid COPD-Depression/Anxiety Population

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.